Hansen Pharmaceutical: Terminates investment project and agrees to collect RMB 30.0983 million

Hansen Pharmaceutical announced that the company had previously signed an investment project agreement related to the Longling Industrial Development Zone with Yiyang Longling Construction Investment Co., Ltd. and the Yiyang Longling Industrial Development Center. As of the announcement date, no substantive construction has been carried out for the project. Due to changes in the pharmaceutical industry environment, the company recently signed a project termination agreement with the two parties, stipulating that Yiyang Longling Construction Investment Co., Ltd. shall pay a performance bond and related interest of RMB 26.2244 million and compensate for subsequent expenses of RMB 3.8739 million, totaling RMB 30.0983 million; upon full payment, the original agreement shall terminate.